Active, Not Recruiting
Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
NCT03941132
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Mount Sinai Hospital/UHN Toronto, British Columbia, Canada
- BCDiabetes Vancouver, British Columbia, Canada